These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The prognostic impact of the extent of lymph node dissection in patients with stage III melanoma. Galliot-Repkat C, Cailliod R, Trost O, Danino A, Collet E, Lambert D, Vabres P, Dalac S. Eur J Surg Oncol; 2006 Sep; 32(7):790-4. PubMed ID: 16822643 [Abstract] [Full Text] [Related]
13. Significance of clinical stage, extent of surgery, and pathologic findings in metastatic cutaneous squamous carcinoma of the parotid gland. O'Brien CJ, McNeil EB, McMahon JD, Pathak I, Lauer CS, Jackson MA. Head Neck; 2002 May; 24(5):417-22. PubMed ID: 12001070 [Abstract] [Full Text] [Related]
14. Malignant melanoma: correlation of long-term follow-up with clinical staging, level of invasion and thickness of the primary tumor. Geelhoed GW, Breslow A, McCune WS. Am Surg; 1977 Feb; 43(2):77-85. PubMed ID: 835903 [Abstract] [Full Text] [Related]
15. [Prognosis of malignant melanoma following dissection regional lymph node metastases]. Sprakel B, Stenschke F, Unnewehr M, Ladas A, Senninger N. Chirurg; 2003 Jan; 74(1):55-60. PubMed ID: 12552406 [Abstract] [Full Text] [Related]
16. Sentinel node status in melanoma patients is not predictive for overall survival upon multivariate analysis. Roka F, Kittler H, Cauzig P, Hoeller C, Hinterhuber G, Wolff K, Pehamberger H, Diem E. Br J Cancer; 2005 Feb 28; 92(4):662-7. PubMed ID: 15700039 [Abstract] [Full Text] [Related]
17. [Prognosis after sentinel node biopsy in malignant melanoma]. Lock-Andersen J, Horn J, Sjøstrand H. Ugeskr Laeger; 2006 Jun 19; 168(25):2457-62. PubMed ID: 16824370 [Abstract] [Full Text] [Related]
18. [Sentinel lymph node dissection in patients with malignant melanoma. Diagnostic and therapeutic standards]. Arens A, Osinga J, Schwipper V, Schober O, Tilkorn H, Liebau J. Chirurg; 2003 Jul 19; 74(7):665-70. PubMed ID: 12883795 [Abstract] [Full Text] [Related]
19. Prognostic variables for patients with stage III malignant melanoma. Messaris GE, Konstadoulakis MM, Ricaniadis N, Leandros E, Androulakis G, Karakousis PC. Eur J Surg; 2000 Mar 19; 166(3):233-9. PubMed ID: 10755339 [Abstract] [Full Text] [Related]